BioCorRx (BICX) Revenue (2011 - 2026)
BioCorRx (BICX) posted Revenue of $214,539 for Q1 2026, up 59.0% from $134,899 a year earlier.
Powered by 
Analysis
BioCorRx (BICX) Revenue (2011 - 2026) Analysis & Trends
For the trailing twelve months through Mar 31, 2026, Revenue at BioCorRx was $876,883, up 531.1% year-over-year; for FY2025, it came in at $797,244.
- Annual Revenue shows a five-year compound annual growth rate of 45.4% (FY2020 to FY2025).
- In prior years, BioCorRx's Revenue was $7,665 in FY2024 (-91.4%), $89,160 in FY2023 (-58.3%), $213,841 in FY2022 (+343.0%) and $48,272 in FY2021 (-60.6%).
- Quarterly Revenue has run from a low of -$151,118 in Q4 2025 to a high of $635,224 in Q3 2025 over five years.
- The strongest year-over-year quarter for Revenue in the past five years was Q3 2022, with growth of 971.1%; the weakest was Q1 2024, with a decline of 91.0%.
- According to Business Quant data, Revenue for the three prior quarters was -$151,118 (Q4 2025), $635,224 (Q3 2025) and $178,238 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.33 Bn |
| 10 | BioCorRx | 3.46 Mn | 2.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 214,539.00 |
| Dec 31, 2025 | -151,118.00 |
| Sep 30, 2025 | 635,224.00 |
| Jun 30, 2025 | 178,238.00 |
| Mar 31, 2025 | 134,899.00 |
| Jun 30, 2024 | 4,045.00 |
| Mar 31, 2024 | 3,620.00 |
| Dec 31, 2023 | 18,938.00 |
| Sep 30, 2023 | 10,145.00 |
| Jun 30, 2023 | 19,635.00 |
| Mar 31, 2023 | 40,442.00 |
| Dec 31, 2022 | 82,880.00 |
| Sep 30, 2022 | 94,441.00 |
| Jun 30, 2022 | 16,002.00 |
| Mar 31, 2022 | 20,518.00 |
| Dec 31, 2021 | 13,613.00 |
| Sep 30, 2021 | 8,817.00 |
| Jun 30, 2021 | 15,718.00 |
| Mar 31, 2021 | 10,124.00 |
| Dec 31, 2020 | 22,222.00 |
API Access
BioCorRx Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=BICX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "BICX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=BICX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();